|
- ARUP Laboratories | National Reference Laboratory
ARUP provides reference laboratory testing for hospitals and health centers, serving the diagnostic needs of patients We also consult on lab management, utilization, and operations
- Magnify Summer 2025 | ARUP Laboratories
Although cancer incidence in those older than 50 years has declined in recent years, a concerning upward trend has emerged as incidence in younger populations has increased But the news isn’t all bad Laboratory medicine has made great strides in screening methods that are more accessible and less invasive Early screening and detection can dramatically alter the outcomes for patients
- ARUP Medical Director To Present on the Progressive Plasma pTau 217 . . .
Join ARUP at the 2025 AAN Annual Meeting to explore the latest in diagnostic laboratory testing for autoimmune neurology, including a presentation on a new biomarker test for Alzheimer's disease
- Education - ARUP Laboratories
We apply our academic expertise to improve patient care by providing over 145,000 continuing education credits annually for clients, physicians, and laboratory professionals at no cost, through our online CME, P A C E ®, and Florida continuing education courses
- Allergen, Region 14 Respiratory Panel IgE, Central California (CA . . .
Allergen testing for patients in the central California region (California) ||Separate from cells ASAP or within 2 hours of collection Transfer 4 mL serum to an ARUP Standard Transport Tube (Min: 1 3 mL) Serum Separator Tube (SST) Multiple specimen tubes should be avoided
- Laboratory Test Directory - ARUP Lab
Search our extensive Laboratory Test Directory to find test codes, ordering recommendations, specimen stability information, Test Fact Sheets, and more
- Measles Virus Testing | ARUP Laboratories
ARUP Laboratories will be the first reference laboratory to offer a molecular measles test that both detects the measles virus and distinguishes between disease-causing and vaccine strains of the virus
- Anti-Mutated Citrullinated Vimentin (MCV) Antibody, Serum
Anti-MCV antibody concentrations of ≥20 U mL is used as a positivity cutoff according to the assay's package insert and an internal verification study Positive results should be interpreted in the context of patient's clinical presentation, laboratory and or radiologic findings, and current disease guidelines Anti-MCV can be found in patients negative for anti-CCP antibodies Anti-MCV can
|
|
|